Promotions & Moves

Ascletis Pharma Appoints CFO

Dr. Tan is a healthcare professional with extensive knowledge in the biotech sector

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Dr. Lindi Tan has been appointed chief financial officer, Ascletis Pharma Inc., a commercial-stage biopharma company focused on therapeutic areas including anti-viral, cancer and fatty liver diseases. Dr. Tan is a healthcare professional with extensive knowledge in the biotech sector. Prior to joining Ascletis, Dr. Tan held roles at SeaTown Holdings International and Temasek International. Dr. Tan was the global healthcare analyst at SeaTown and was responsible for driving multi-asset investm...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters